Key result
Dexmedetomidine sedation during AF ablation cuts respiratory disturbance index by ~43% vs thiamylal.
Why the study?
Procedural sedation by non-anaesthesiologists with GABAergic anaesthetics carries a risk of fatal respiratory depression, and dexmedetomidine may offer safer sedation during AF ablation.
Does dexmedetomidine improve respiratory safety and patient immobility compared to thiamylal during ablation of atrial fibrillation?
RCT (n=87)
randomized
Does dexmedetomidine improve respiratory safety and patient immobility compared to thiamylal during ablation of atrial fibrillation?
Dexmedetomidine provides a safer respiratory profile and better patient immobility compared to thiamylal during AF ablation, although rescue sedation is frequently required.
Answers are grounded in this paper and cite their sources.
May favor dexmedetomidine for sedation in AF ablation to reduce respiratory events; extends RCT options for safer procedural sedation in electrophysiology.
AIMS: Procedural sedation by non-anaesthesiologists with GABAergic anaesthetics has the potential risk of fatal respiratory depression. Dexmedetomidine works its sedative action via α2-adrenergic receptors, and is less associated with respiratory depression. We tested the usability of dexmedetomidine as a procedural sedative during ablation of atrial fibrillation (AF). METHODS AND RESULTS: Consecutive patients were randomized to be treated with dexmedetomidine (n = 43) or thiamylal (n = 44) as sedatives during AF ablation. Apnoeic and body movement events were monitored using a novel portable respiratory monitor, the SD-101, during the procedure. Although the majority of the patients receiving dexmedetomidine required rescue sedations with thiamylal, the respiratory disturbance index (RDI) defined as the total number of sleep-disordered breathing events divided by the recording time (10.4 ± 5.1 vs. 18.2 ± 8.1 events/h; P < 0.0001) and movement index defined as the number of body movement events per hour (7.6 ± 6.1 vs. 11.0 ± 5.5 events/h; P = 0.0098) were both significantly lower in the dexmedetomidine arm than in the thiamylal arm. A multivariate linear regression analysis including potential factors revealed that dexmedetomidine vs. thiamylal was solely and independently associated with the RDI (β = -0.62; P = 0.0031). The occurrence of hypotension [9 (21%) vs. 4 (9%); P = 0.14] and bradycardia [4 (9%) vs. 4 (9%); P = 1.0] were similar in the patients with dexmedetomidine and thiamylal. CONCLUSION: Procedural sedation with dexmedetomidine may assure safety and patient immobility during AF ablation, and therefore may be a potential alternative for that with GABAergic anaesthetics.
No takes yet. Share an insight, caveat, or question.
Sairaku et al. (2013) conducted an RCT in Atrial fibrillation (n=87). Dexmedetomidine vs. Thiamylal was evaluated on Respiratory disturbance index (RDI) (p=< 0.0001). Procedural sedation with dexmedetomidine during atrial fibrillation ablation reduced the respiratory disturbance index compared to thiamylal.
Synapse has enriched 10 related papers. Consider them for comparative context: